Baxter International Inc. (BAX) boasts a market cap of $9.4 billion, offering a wide range of hospital products and therapies. The company’s market leadership is evident in the medical instruments & supplies industry. Despite recent declines, its shares remain strong in the industry.

BAX shares have seen a 49.9% drop from their 52-week high, underperforming the Health Care Select Sector SPDR Fund. The stock’s long-term performance shows significant decreases, trading below moving averages since early April.

Baxter’s announcement of a quarterly cash dividend of 0.01 dollars per share led to a 2.8% increase in its share value. Despite this, its rival Becton, Dickinson and Company (BDX) has outpaced BAX in stock performance.

Analysts are cautious about BAX’s future, giving it a consensus “Hold” rating. The mean price target of $22.29 suggests a potential upside of 17.9% from the current price levels.

Read more at Yahoo Finance: Is BAX Underperforming the Health Care Sector?